| Year |
Citation |
Score |
| 2023 |
Jørgensen HS, Claes K, Smout D, Naesens M, Kuypers D, D'Haese P, Cavalier E, Evenepoel P. Associations of Changes in Bone Turnover Markers with Change in Bone Mineral Density in Kidney Transplant Patients. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 38030558 DOI: 10.2215/CJN.0000000000000368 |
0.426 |
|
| 2023 |
David K, Dubois V, Verhulst A, Sommers V, Schollaert D, Deboel L, Moermans K, Carmeliet G, D'Haese P, Vanderschueren D, Claessens F, Evenepoel P, Decallonne B. Androgen therapy does not prevent bone loss and arterial calcifications in male rats with CKD. The Journal of Endocrinology. PMID 36951580 DOI: 10.1530/JOE-22-0319 |
0.395 |
|
| 2023 |
Huybrechts Y, Evenepoel P, Haarhaus M, Cavalier E, Dams G, Van Hul W, D'Haese PC, Verhulst A. Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover. Nutrients. 15. PMID 36771305 DOI: 10.3390/nu15030598 |
0.497 |
|
| 2022 |
Jørgensen HS, Ferreira AC, D'Haese P, Haarhaus M, Vervloet M, Lafage-Proust MH, Ferreira A, Evenepoel P. Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges. Kidney International. PMID 35643374 DOI: 10.1016/j.kint.2022.04.030 |
0.494 |
|
| 2022 |
Van den Branden A, Verhulst A, D'Haese PC, Opdebeeck B. New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization? Metabolites. 12. PMID 35448514 DOI: 10.3390/metabo12040327 |
0.363 |
|
| 2022 |
Meng C, Jørgensen HS, Verlinden L, Bravenboer N, de Loor H, D'Haese PC, Carmeliet G, Evenepoel P. Contemporary kidney transplantation has a limited impact on bone microarchitecture. Bone Reports. 16: 101172. PMID 35198658 DOI: 10.1016/j.bonr.2022.101172 |
0.447 |
|
| 2022 |
Jørgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, Cavalier E, D'Haese P, Evenepoel P. Natural History of Bone Disease following Kidney Transplantation. Journal of the American Society of Nephrology : Jasn. PMID 35046132 DOI: 10.1681/ASN.2021081081 |
0.382 |
|
| 2022 |
De Maré A, Opdebeeck B, Neven E, D'Haese PC, Verhulst A. Sclerostin Protects Against Vascular Calcification Development in Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 35038187 DOI: 10.1002/jbmr.4503 |
0.363 |
|
| 2022 |
Jørgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, D'Haese P, Evenepoel P. Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 36: 2130-2139. PMID 34383929 DOI: 10.1093/ndt/gfab239 |
0.461 |
|
| 2021 |
Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, Cavalier E, D'Haese P, Evenepoel P. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 34710517 DOI: 10.1053/j.ajkd.2021.07.027 |
0.5 |
|
| 2021 |
Bourne LE, Patel JJ, Davies BK, Neven E, Verhulst A, D'Haese PC, Wheeler-Jones CPD, Orriss IR. N-acetylcysteine (NAC) differentially affects arterial medial calcification and bone formation: The role of l-cysteine and hydrogen sulphide. Journal of Cellular Physiology. PMID 34658034 DOI: 10.1002/jcp.30605 |
0.311 |
|
| 2021 |
Opdebeeck B, Neven E, Millán JL, Pinkerton AB, D'Haese PC, Verhulst A. Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the Enzyme. Pharmaceutics. 13. PMID 34452102 DOI: 10.3390/pharmaceutics13081138 |
0.475 |
|
| 2021 |
Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, D'Haese PC, Evenepoel P. Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone. 152: 116066. PMID 34147707 DOI: 10.1016/j.bone.2021.116066 |
0.465 |
|
| 2021 |
Ferreira AC, Cohen-Solal M, D'Haese PC, Ferreira A. The Role of Bone Biopsy in the Management of CKD-MBD: CKD-Related Osteoporosis or CKD-MBD/Osteoporosis? Calcified Tissue International. PMID 33914095 DOI: 10.1007/s00223-021-00854-z |
0.424 |
|
| 2021 |
Ferreira AC, Cohen-Solal M, D'Haese PC, Ferreira A. The Role of Bone Biopsy in the Management of CKD-MBD. Calcified Tissue International. PMID 33772341 DOI: 10.1007/s00223-021-00838-z |
0.461 |
|
| 2021 |
Ursem SR, Heijboer AC, D'Haese PC, Behets GJ, Cavalier E, Vervloet MG, Evenepoel P. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease. Kidney International. PMID 33422551 DOI: 10.1016/j.kint.2020.12.024 |
0.442 |
|
| 2020 |
Mace ML, Gravesen E, Nordholm A, Egstrand S, Morevati M, Nielsen C, Kjaer A, Behets G, D'Haese P, Olgaard K, Lewin E. Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 36: 510-522. PMID 33301619 DOI: 10.1002/jbmr.4203 |
0.483 |
|
| 2020 |
Neven E, Corremans R, Vervaet BA, Funk F, Walpen S, Behets GJ, D'Haese PC, Verhulst A. Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 35: 1689-1699. PMID 33022710 DOI: 10.1093/ndt/gfaa080 |
0.456 |
|
| 2020 |
Nickolas TL, Chen N, McMahon DJ, Dempster D, Zhou H, Dominguez J, Aponte MA, Sung J, Evenepoel P, D'Haese PC, Mac-Way F, Moyses R, Moe S. A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy. Jbmr Plus. 4: e10353. PMID 32490328 DOI: 10.1002/jbm4.10353 |
0.316 |
|
| 2020 |
Novel-Catin E, Pelletier S, Fouque D, Roux JP, Chapurlat R, D'Haese P, Behets G, Evenepoel P, Nickolas TL, Lafage-Proust MH. Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples. Bone. 138: 115460. PMID 32485361 DOI: 10.1016/J.Bone.2020.115460 |
0.473 |
|
| 2020 |
Maré A, D'Haese PC, Verhulst A. The Role of Sclerostin in Bone and Ectopic Calcification. International Journal of Molecular Sciences. 21. PMID 32366042 DOI: 10.3390/Ijms21093199 |
0.554 |
|
| 2020 |
Opdebeeck B, Neven E, Millán JL, Pinkerton AB, D'Haese PC, Verhulst A. Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation/mineralization impairment. Bone. 115392. PMID 32360899 DOI: 10.1016/J.Bone.2020.115392 |
0.43 |
|
| 2020 |
Behets GJ, Mubiana KV, Lamberts L, Finsterle K, Traill N, Blust R, D'Haese PC. Use of lanthanum for water treatment A matter of concern? Chemosphere. 239: 124780. PMID 31726528 DOI: 10.1016/J.Chemosphere.2019.124780 |
0.323 |
|
| 2020 |
Evenepoel P, Claes K, Cavalier E, Meijers B, Stenvinkel P, Behets G, Jankowska M, D'Haese P, Bammens B. A distinct bone phenotype in ADPKD patients with end-stage renal disease. Kidney International. 95: 412-419. PMID 30665572 DOI: 10.1016/J.Kint.2018.09.018 |
0.594 |
|
| 2020 |
Ursem S, Heijboer A, D'Haese P, Behets G, Vervloet M, Evenepoel P. P1388Assessing Bone Turnover In Chronic Kidney Disease: Should We Measure Non-Oxidized Pth Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P1388 |
0.51 |
|
| 2020 |
Opdebeeck B, Luis JM, Pinkerton A, Verhulst A, D'Haese P, Neven E. P1237Tissue-Nonspecific Alkaline Phosphatase, A Culprit During Arterial Media Calcification But Indispensable During Physiological Bone Formation/-Mineralization In Rats Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P1237 |
0.476 |
|
| 2020 |
Corremans R, Vervaet B, D'Haese P, Verhulst A. P0104Therapeutic Metformin Treatment Is Able To Halt The Progression Of Chronic Kidney Disease In Rats Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P0104 |
0.361 |
|
| 2020 |
Schreurs G, Nast C, Maudsley S, D'Haese P, Broe MD, Vervaet B. P0099Calcineurin Inhibition, But Not Dehydration, In Rats Mimics Human Renal Histopathology Of Patients With Chronic Interstitial Nephritis In Agricultural Communities (Cinac) Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P0099 |
0.421 |
|
| 2020 |
Mace ML, Gravesen E, Nordholm A, Egstrand S, Morevati M, Behets G, D'Haese P, Olgaard K, Lewin E. Mo054Vascular Calcification Impairs Bone Mineralization Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa140.Mo054 |
0.521 |
|
| 2019 |
Opdebeeck B, D'Haese PC, Verhulst A. Inhibition of tissue non-specific alkaline phosphatase, a novel therapy against arterial media calcification? The Journal of Pathology. PMID 31859361 DOI: 10.1002/Path.5377 |
0.369 |
|
| 2019 |
Evenepoel P, Opdebeeck B, David K, D'Haese PC. Bone-Vascular Axis in Chronic Kidney Disease. Advances in Chronic Kidney Disease. 26: 472-483. PMID 31831125 DOI: 10.1053/J.Ackd.2019.09.006 |
0.545 |
|
| 2019 |
Maré A, Verhulst A, Cavalier E, Delanaye P, Behets GJ, Meijers B, Kuypers D, D'Haese PC, Evenepoel P. Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine. 8. PMID 31756992 DOI: 10.3390/jcm8122027 |
0.484 |
|
| 2019 |
Evenepoel P, Cavalier E, D'Haese PC. Bone biomarkers in de novo renal transplant recipients. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 31734147 DOI: 10.1016/J.Cca.2019.10.035 |
0.577 |
|
| 2019 |
De Maré A, Maudsley S, Azmi A, Hendrickx JO, Opdebeeck B, Neven E, D'Haese PC, Verhulst A. Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone-Vascular Axis. Toxins. 11. PMID 31330917 DOI: 10.3390/Toxins11070428 |
0.387 |
|
| 2019 |
Müller KH, Hayward R, Rajan R, Whitehead M, Cobb AM, Ahmad S, Sun M, Goldberga I, Li R, Bashtanova U, Puszkarska AM, Reid DG, Brooks RA, Skepper JN, Bordoloi J, et al. Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization. Cell Reports. 27: 3124-3138.e13. PMID 31189100 DOI: 10.1016/J.Celrep.2019.05.038 |
0.427 |
|
| 2018 |
Corremans R, Vervaet BA, D'Haese PC, Neven E, Verhulst A. Metformin: A Candidate Drug for Renal Diseases. International Journal of Molecular Sciences. 20. PMID 30583483 DOI: 10.3390/ijms20010042 |
0.323 |
|
| 2018 |
Boltenstål H, Qureshi AR, Behets GJ, Lindholm B, Stenvinkel P, D'Haese PC, Haarhaus M. Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients. Calcified Tissue International. PMID 30406279 DOI: 10.1007/s00223-018-0491-4 |
0.507 |
|
| 2018 |
Moonen L, D'Haese PC, Vervaet BA. Epithelial Cell Cycle Behaviour in the Injured Kidney. International Journal of Molecular Sciences. 19. PMID 30011818 DOI: 10.3390/Ijms19072038 |
0.32 |
|
| 2018 |
Brandenburg VM, Verhulst A, Babler A, D'Haese PC, Evenepoel P, Kaesler N. Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it! Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29846712 DOI: 10.1093/Ndt/Gfy129 |
0.536 |
|
| 2018 |
Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Kidney International. PMID 29716795 DOI: 10.1016/j.kint.2018.01.027 |
0.477 |
|
| 2018 |
Hendrickx G, Borra VM, Steenackers E, Yorgan TA, Hermans C, Boudin E, Waterval JJ, Jansen IDC, Aydemir TB, Kamerling N, Behets GJ, Plumeyer C, D'Haese PC, Busse B, Everts V, et al. Conditional mouse models support the role of SLC39A14 (ZIP14) in Hyperostosis Cranialis Interna and in bone homeostasis. Plos Genetics. 14: e1007321. PMID 29621230 DOI: 10.1371/Journal.Pgen.1007321 |
0.528 |
|
| 2018 |
Kaesler N, Verhulst A, De Maré A, Deck A, Behets GJ, Hyusein A, Evenepoel P, Floege J, Marx N, Babler A, Kramer I, Kneissel M, Kramann R, Weis D, D'Haese PC, et al. Sclerostin deficiency modifies the development of CKD-MBD in mice. Bone. 107: 115-123. PMID 29175269 DOI: 10.1016/J.Bone.2017.11.015 |
0.534 |
|
| 2018 |
Neven E, Walpen S, Verhulst A, Britt O, Funk F, D'Haese P. FP299EFFECT OF SUCROFERRIC OXYHYDROXIDE (PA21) ON RENAL FUNCTION, MINERAL HOMEOSTASIS AND VASCULAR CALCIFICATION IN A RAT MODEL WITH CHRONIC KIDNEY DISEASE (CKD) Nephrology Dialysis Transplantation. 33: i132-i132. DOI: 10.1093/Ndt/Gfy104.Fp299 |
0.459 |
|
| 2018 |
Moonen L, Cuypers B, Meysman P, Laukens K, D'Haese P, Vervaet B. FO017UNILATERAL NEPHRECTOMY SUPPRESSES IMMUNE RESPONSE PATHWAYS IN ACUTE KIDNEY INJURY AND OVERCOMES PROGRESSION TO CHRONIC KIDNEY DISEASE IN MICE Nephrology Dialysis Transplantation. 33: i8-i8. DOI: 10.1093/Ndt/Gfy104.Fo017 |
0.335 |
|
| 2017 |
De Rechter S, Bacchetta J, Godefroid N, Dubourg L, Cochat P, Maquet J, Raes A, De Schepper J, Vermeersch P, Van Dyck M, Levtchenko E, D'Haese P, Evenepoel P, Mekahli D. Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease. The Journal of Clinical Endocrinology and Metabolism. 102: 4210-4217. PMID 29092060 DOI: 10.1210/jc.2017-01157 |
0.398 |
|
| 2017 |
Patel JJ, Zhu D, Opdebeeck B, D'Haese P, Millán JL, Bourne LE, Wheeler-Jones CPD, Arnett TR, MacRae VE, Orriss IR. Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms. Journal of Cellular Physiology. PMID 28976001 DOI: 10.1002/Jcp.26166 |
0.429 |
|
| 2017 |
Evenepoel P, Behets GJS, Laurent MR, D'Haese PC. Update on the role of bone biopsy in the management of patients with CKD-MBD. Journal of Nephrology. 30: 645-652. PMID 28831679 DOI: 10.1007/s40620-017-0424-8 |
0.529 |
|
| 2017 |
Vervaet BA, Moonen L, Godderis L, Poels K, D'Haese PC. Untargeted DNA-Demethylation Therapy Neither Prevents Nor Attenuates Ischemia-Reperfusion-Induced Renal Fibrosis. Nephron. PMID 28750405 DOI: 10.1159/000477507 |
0.351 |
|
| 2017 |
Verhulst A, Neven E, D'Haese PC. Characterization of an Animal Model to Study Risk Factors and New Therapies for the Cardiorenal Syndrome, a Major Health Issue in Our Aging Population. Cardiorenal Medicine. 7: 234-244. PMID 28736564 DOI: 10.1159/000462984 |
0.337 |
|
| 2017 |
Leifheit-Nestler M, Kucka J, Yoshizawa E, Behets G, D'Haese P, Bergen C, Meier M, Fischer DC, Haffner D. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia. Bone. 103: 224-232. PMID 28728941 DOI: 10.1016/J.Bone.2017.06.019 |
0.425 |
|
| 2017 |
Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. Plos One. 12: e0176411. PMID 28493902 DOI: 10.1371/journal.pone.0176411 |
0.368 |
|
| 2017 |
Boudin E, Yorgan T, Fijalkowski I, Sonntag S, Steenackers E, Hendrickx G, Peeters S, De Maré A, Vervaet B, Verhulst A, Mortier G, D'Haese P, Schinke T, Van Hul W. The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 32: 1739-1749. PMID 28477420 DOI: 10.1002/Jbmr.3160 |
0.52 |
|
| 2017 |
Evenepoel P, Cavalier E, D'Haese PC. Biomarkers Predicting Bone Turnover in the Setting of CKD. Current Osteoporosis Reports. PMID 28429254 DOI: 10.1007/S11914-017-0362-3 |
0.552 |
|
| 2017 |
Evenepoel P, D'Haese P, Bacchetta J, Cannata-Andia J, Ferreira A, Haarhaus M, Mazzaferro S, Lafage Proust MH, Salam S, Spasovski G, Cozzolino M. Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 28339949 DOI: 10.1093/ndt/gfw468 |
0.515 |
|
| 2017 |
Verhulst A, Evenepoel P, D'Haese PC. Ligand trap for the activin type IIA receptor. The long-sought drug to overcome the calcification paradox in CKD? Kidney International. 91: 11-13. PMID 28003078 DOI: 10.1016/J.Kint.2016.09.050 |
0.488 |
|
| 2017 |
De Rechter S, Bacchetta J, Godefroid N, Dubourg L, Cochat P, Macquet J, Raes A, De Schepper J, Vermeersch P, Van Dyck M, D'Haese P, Levtchenko E, Evenepoel P, Mekahli D. MO044DO WE HAVE EVIDENCE FOR BONE AND MINERAL METABOLISM ALTERATIONS IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE? Nephrology Dialysis Transplantation. 32: iii61-iii61. DOI: 10.1093/Ndt/Gfx121.Mo044 |
0.489 |
|
| 2016 |
Evenepoel P, Behets GJ, Viaene L, D'Haese PC. Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney International. PMID 27998642 DOI: 10.1016/J.Kint.2016.10.008 |
0.559 |
|
| 2016 |
Cabrera WE, Behets G, Lamberts L, D'Haese P. [Blood lead levels and markers of renal dysfunction among mechanical workshop workers]. Revista Medica De Chile. 144: 704-709. PMID 27598488 DOI: 10.4067/S0034-98872016000600003 |
0.356 |
|
| 2016 |
Glorie L, D'Haese PC, Verhulst A. Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors. Bone. 92: 37-49. PMID 27535784 DOI: 10.1016/J.Bone.2016.08.009 |
0.429 |
|
| 2016 |
Evenepoel P, Behets GJS, Viaene L, D'Haese PC. SO032BONE AND MINERAL STATUS ONE YEAR AFTER RENAL TRANSPLANTATION Nephrology Dialysis Transplantation. 31: i14-i14. DOI: 10.1093/Ndt/Gfw122.05 |
0.396 |
|
| 2015 |
Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, D'Haese P, Evenepoel P, Verbeke K, Meijers B. The Influence of CKD on Colonic Microbial Metabolism. Journal of the American Society of Nephrology : Jasn. 27: 1389-99. PMID 26400570 DOI: 10.1681/ASN.2015030279 |
0.319 |
|
| 2015 |
Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 26321176 DOI: 10.1053/j.ajkd.2015.06.023 |
0.5 |
|
| 2015 |
Viaene L, Behets GJ, Heye S, Claes K, Monbaliu D, Pirenne J, D'Haese PC, Evenepoel P. Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 27: 489-97. PMID 26294291 DOI: 10.1007/S00198-015-3233-8 |
0.569 |
|
| 2015 |
Neven E, Bashir-Dar R, Dams G, Behets GJ, Verhulst A, Elseviers M, D'Haese PC. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 2313-24. PMID 26108730 DOI: 10.1002/Jbmr.2585 |
0.565 |
|
| 2015 |
Evenepoel P, D'Haese P, Brandenburg V. Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney International. 88: 235-40. PMID 26083653 DOI: 10.1038/Ki.2015.156 |
0.543 |
|
| 2015 |
Sinnesael M, Laurent MR, Jardi F, Dubois V, Deboel L, Delisser P, Behets GJ, D'Haese PC, Carmeliet G, Claessens F, Vanderschueren D. Androgens inhibit the osteogenic response to mechanical loading in adult male mice. Endocrinology. 156: 1343-53. PMID 25654322 DOI: 10.1210/En.2014-1673 |
0.312 |
|
| 2015 |
Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney International. 87: 846-56. PMID 25337774 DOI: 10.1038/Ki.2014.349 |
0.562 |
|
| 2015 |
Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism Kidney International. 87: 846-856. DOI: 10.1038/ki.2014.349 |
0.37 |
|
| 2014 |
Neven E, De Schutter TM, Dams G, Gundlach K, Steppan S, Büchel J, Passlick-Deetjen J, D'Haese PC, Behets GJ. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats. Plos One. 9: e107067. PMID 25229549 DOI: 10.1371/Journal.Pone.0107067 |
0.558 |
|
| 2014 |
Glorie L, Behets GJ, Baerts L, De Meester I, D'Haese PC, Verhulst A. DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats. American Journal of Physiology. Endocrinology and Metabolism. 307: E447-55. PMID 25053403 DOI: 10.1152/Ajpendo.00217.2014 |
0.469 |
|
| 2014 |
D'Haese PC, Behets GJ, Neven E, Verhulst A. Regarding: "Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn2+ and Mg 2+". Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 27: 609-10. PMID 24919529 DOI: 10.1007/s10534-014-9759-y |
0.306 |
|
| 2014 |
Behets GJ, Dams G, Damment SJ, Martin P, De Broe ME, D'Haese PC. Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders. American Journal of Physiology. Renal Physiology. 306: F61-7. PMID 24197066 DOI: 10.1152/Ajprenal.00219.2013 |
0.36 |
|
| 2013 |
Claes KJ, Viaene L, Heye S, Meijers B, d'Haese P, Evenepoel P. Sclerostin: Another vascular calcification inhibitor? The Journal of Clinical Endocrinology and Metabolism. 98: 3221-8. PMID 23788689 DOI: 10.1210/Jc.2013-1521 |
0.412 |
|
| 2013 |
Viaene L, Behets GJ, Claes K, Meijers B, Blocki F, Brandenburg V, Evenepoel P, D'Haese PC. Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 28: 3024-30. PMID 23605174 DOI: 10.1093/Ndt/Gft039 |
0.506 |
|
| 2013 |
De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K, Passlick-Deetjen J, D'Haese PC, Neven E. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney International. 83: 1109-17. PMID 23486515 DOI: 10.1038/ki.2013.34 |
0.323 |
|
| 2012 |
De Schutter TM, Behets GJ, Jung S, Neven E, D'Haese PC, Querfeld U. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats. Calcified Tissue International. 91: 307-15. PMID 22926202 DOI: 10.1007/s00223-012-9635-0 |
0.389 |
|
| 2012 |
Glorie LL, Verhulst A, Matheeussen V, Baerts L, Magielse J, Hermans N, D'Haese PC, De Meester I, De Beuf A. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology. 303: F681-8. PMID 22718884 DOI: 10.1152/Ajprenal.00075.2012 |
0.323 |
|
| 2012 |
Fischer DC, Behets GJ, Hakenberg OW, Voigt M, Vervaet BA, Robijn S, Kundt G, Schareck W, D'Haese PC, Haffner D. Arterial microcalcification in atherosclerotic patients with and without chronic kidney disease: a comparative high-resolution scanning X-ray diffraction analysis. Calcified Tissue International. 90: 465-72. PMID 22476351 DOI: 10.1007/s00223-012-9594-5 |
0.318 |
|
| 2012 |
Block G, Bell* G, Pickthorn K, Huang S, Martin K, Tentori F, Bieber B, Morgenstern H, Jacobson S, Andreucci V, Fukagawa M, Mendelssohn D, Pisoni R, Robinson B, De Schutter T, et al. Bone and mineral diseases - 2 Nephrology Dialysis Transplantation. 27: ii52-ii54. DOI: 10.1093/Ndt/Gfs202 |
0.512 |
|
| 2012 |
Walter* S, Dong J, Alexander S, Hunter T, Yin K, Maclean D, Tomlinson J, Karim F, Johnson R, Stevens K, Patel R, Clancy M, Graham D, Delles C, Jardine A, et al. Bone and mineral diseases - 1 Nephrology Dialysis Transplantation. 27: ii36-ii37. DOI: 10.1093/Ndt/Gfs193 |
0.512 |
|
| 2012 |
De Schutter⁎ T, Behets G, Jung S, Neven E, D'Haese P, Querfeld U. Restoration of bone mineralization by cinacalcet or parathyroidectomy is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats Bone. 50: S177. DOI: 10.1016/J.Bone.2012.02.558 |
0.491 |
|
| 2012 |
Glorie⁎ L, Leclef N, Verhulst A, Behets G, Hervent A, De Keulenaer G, D'Haese P. DPP4 inhibition may ameliorate bone turnover in diabetic mice Bone. 50: S171. DOI: 10.1016/J.Bone.2012.02.537 |
0.392 |
|
| 2012 |
Glorie⁎ L, Leclef N, Verhulst A, Behets G, Matheeussen V, De Meester I, D'Haese P. DPP4 inhibition alters the pathophysiology of osteoporosis Bone. 50: S140. DOI: 10.1016/J.Bone.2012.02.434 |
0.3 |
|
| 2011 |
De Schutter TM, Neven E, Persy VP, Behets GJ, Postnov AA, De Clerck NM, D'Haese PC. Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox. American Journal of Nephrology. 34: 356-66. PMID 21876348 DOI: 10.1159/000331056 |
0.528 |
|
| 2011 |
Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney International. 80: 1146-58. PMID 21866092 DOI: 10.1038/Ki.2011.287 |
0.41 |
|
| 2011 |
Fischer DC, Jensen C, Rahn A, Salewski B, Kundt G, D'Haese PC, Haffner D, Behets GJ. Moderate strontium loading induces rickets in rats with mild chronic renal failure. Kidney & Blood Pressure Research. 34: 375-81. PMID 21654178 DOI: 10.1159/000328329 |
0.371 |
|
| 2011 |
Neven E, De Schutter TM, De Broe ME, D'Haese PC. Cell biological and physicochemical aspects of arterial calcification. Kidney International. 79: 1166-77. PMID 21412217 DOI: 10.1038/Ki.2011.59 |
0.461 |
|
| 2011 |
Neven E, De Schutter TM, Behets GJ, Gupta A, D'Haese PC. Iron and vascular calcification. Is there a link? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 1137-45. PMID 21325349 DOI: 10.1093/Ndt/Gfq858 |
0.322 |
|
| 2011 |
Neven E, D'Haese PC. Vascular calcification in chronic renal failure: what have we learned from animal studies? Circulation Research. 108: 249-64. PMID 21252152 DOI: 10.1161/Circresaha.110.225904 |
0.405 |
|
| 2011 |
Zebger-Gong H, Müller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, Schmidt S, D'Haese PC, Querfeld U. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. Journal of Hypertension. 29: 339-48. PMID 21063202 DOI: 10.1097/Hjh.0B013E328340Aa30 |
0.31 |
|
| 2010 |
Fischer DC, Jensen C, Rahn A, Salewski B, Kundt G, Behets GJ, D'Haese P, Haffner D. Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function. Pediatric Nephrology (Berlin, Germany). 26: 111-7. PMID 20953634 DOI: 10.1007/s00467-010-1660-5 |
0.354 |
|
| 2010 |
Neven E, Persy V, Dauwe S, De Schutter T, De Broe ME, D'Haese PC. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1741-50. PMID 20522801 DOI: 10.1161/Atvbaha.110.204834 |
0.422 |
|
| 2010 |
De Beuf A, Hou XH, D'Haese PC, Verhulst A. Epoetin delta reduces oxidative stress in primary human renal tubular cells. Journal of Biomedicine & Biotechnology. 2010: 395785. PMID 20454536 DOI: 10.1155/2010/395785 |
0.329 |
|
| 2010 |
Ferreira A, Saraiva M, Behets G, Macedo A, Galvão M, D'Haese P, Drüeke TB. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry. Journal of Nephrology. 22: 783-93. PMID 19967658 |
0.434 |
|
| 2010 |
De Schutter T, Neven E, Postnov A, De Clerck N, D'Haese P. Cortical bone loss determines vascular calcification in rats with adenine induced chronic renal failure with and without ovariectomy Bone. 47: S225. DOI: 10.1016/J.Bone.2010.04.536 |
0.561 |
|
| 2009 |
Persy VP, Behets GJ, De Broe ME, D'Haese PC. Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate. International Journal of Nephrology and Renovascular Disease. 2: 1-8. PMID 21694915 DOI: 10.2147/Ijnrd.S5007 |
0.452 |
|
| 2009 |
Persy V, D'Haese P. Vascular calcification and bone disease: the calcification paradox. Trends in Molecular Medicine. 15: 405-16. PMID 19733120 DOI: 10.1016/j.molmed.2009.07.001 |
0.416 |
|
| 2009 |
Vervaet BA, Verhulst A, Dauwe SE, De Broe ME, D'Haese PC. Active renal crystal clearance in rats and humans. Kidney International. 75: 1357-1358. PMID 19483756 DOI: 10.1038/Ki.2009.118 |
0.374 |
|
| 2009 |
Chen B, Lamberts LV, Behets GJ, Zhao T, Zhou M, Liu G, Hou X, Guan G, D'Haese PC. Selenium, lead, and cadmium levels in renal failure patients in China. Biological Trace Element Research. 131: 1-12. PMID 19266172 DOI: 10.1007/s12011-009-8340-y |
0.304 |
|
| 2009 |
Neven EG, De Broe ME, D'Haese PC. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Kidney International. 75: 580-2. PMID 19247382 DOI: 10.1038/Ki.2008.663 |
0.547 |
|
| 2009 |
Bervoets AR, Behets GJ, Schryvers D, Roels F, Yang Z, Verberckmoes SC, Damment SJ, Dauwe S, Mubiana VK, Blust R, De Broe ME, D'Haese PC. Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure. Kidney International. 75: 389-98. PMID 19052535 DOI: 10.1038/Ki.2008.571 |
0.375 |
|
| 2009 |
Vervaet BA, Verhulst A, Dauwe SE, De Broe ME, D'Haese PC. An active renal crystal clearance mechanism in rat and man. Kidney International. 75: 41-51. PMID 18784645 DOI: 10.1038/Ki.2008.450 |
0.325 |
|
| 2009 |
Jugdaohsingh R, Calomme MR, Robinson K, Nielsen F, Anderson SHC, D'Haese P, Geusens P, Loveridge N, Thompson RPH, Powell JJ. Reply to Dr Exley comments on: Jugdaohsingh R et al., Increased longitudinal growth in rats on a silicon depleted diet. Bone 2008;43:596–606 Bone. 44: 1019-1020. DOI: 10.1016/J.Bone.2009.02.002 |
0.362 |
|
| 2009 |
Chen B, Lamberts LV, Behets GJ, Hou XH, Liu G, Guan GJ, D'Haese PC. An epidemiological survey on serum strontium levels in renal failure patients in China Trace Elements and Electrolytes. 26: 122-130. |
0.358 |
|
| 2008 |
Verhulst A, Sayer R, De Broe ME, D'Haese PC, Brown CD. Human proximal tubular epithelium actively secretes but does not retain rosuvastatin. Molecular Pharmacology. 74: 1084-91. PMID 18612079 DOI: 10.1124/Mol.108.047647 |
0.38 |
|
| 2008 |
Jugdaohsingh R, Calomme MR, Robinson K, Nielsen F, Anderson SH, D'Haese P, Geusens P, Loveridge N, Thompson RP, Powell JJ. Increased longitudinal growth in rats on a silicon-depleted diet. Bone. 43: 596-606. PMID 18550464 DOI: 10.1016/J.Bone.2008.04.014 |
0.391 |
|
| 2008 |
Cabrera WE, Behets GJ, Verberckmoes SC, Lamberts LV, Oste L, Bervoets AJ, Barreto S, Walder A, Santa Cruz F, De Broe ME, D'Haese PC. The influence of acidosis on strontium-induced mineralization defects in chronic renal failure rats Trace Elements and Electrolytes. 25: 92-99. |
0.501 |
|
| 2007 |
Oste L, Behets GJ, Dams G, Bervoets AR, Marynissen RL, Geryl H, Van Hoof VO, De Broe ME, D'Haese PC. Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats. Renal Failure. 29: 1-12. PMID 17365904 DOI: 10.1080/08860220601038637 |
0.46 |
|
| 2007 |
Verberckmoes SC, Persy V, Behets GJ, Neven E, Hufkens A, Zebger-Gong H, Müller D, Haffner D, Querfeld U, Bohic S, De Broe ME, D'Haese PC. Uremia-related vascular calcification: More than apatite deposition Kidney International. 71: 298-303. PMID 17149373 DOI: 10.1038/Sj.Ki.5002028 |
0.345 |
|
| 2007 |
Oste L, Verberckmoes SC, Behets GJ, Dams G, Bervoets AR, Van Hoof VO, Bohic S, Drakopoulos M, De Broe ME, D'Haese PC. Strontium incorporates at sites critical for bone mineralization in rats with renal failure X-Ray Spectrometry. 36: 42-49. DOI: 10.1002/Xrs.929 |
0.581 |
|
| 2006 |
Persy V, Postnov A, Neven E, Dams G, De Broe M, D'Haese P, De Clerck N. High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 2110-6. PMID 16840714 DOI: 10.1161/01.ATV.0000236200.02726.f7 |
0.319 |
|
| 2006 |
Persy VP, Behets GJ, Bervoets AR, De Broe ME, D'Haese PC. Lanthanum: a safe phosphate binder. Seminars in Dialysis. 19: 195-9. PMID 16689967 DOI: 10.1111/j.1525-139X.2006.00169.x |
0.414 |
|
| 2006 |
Spasovski GB, Sikole A, Gelev S, Masin-Spasovska J, Freemont T, Webster I, Gill M, Jones C, De Broe ME, D'Haese PC. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 2217-24. PMID 16595583 DOI: 10.1093/Ndt/Gfl146 |
0.465 |
|
| 2006 |
Bervoets AR, Oste L, Behets GJ, Dams G, Blust R, Marynissen R, Geryl H, De Broe ME, D'Haese PC. Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats. Bone. 38: 803-10. PMID 16412714 DOI: 10.1016/J.Bone.2005.11.022 |
0.429 |
|
| 2005 |
Verhulst A, Asselman M, De Naeyer S, Vervaet BA, Mengel M, Gwinner W, D'Haese PC, Verkoelen CF, De Broe ME. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney International. 68: 1643-7. PMID 16164641 DOI: 10.1111/J.1523-1755.2005.00584.X |
0.367 |
|
| 2005 |
Behets GJ, Gritters M, Dams G, De Broe ME, D'Haese PC. Effects of efficient phosphate binding on bone in chronic renal failure rats. Renal Failure. 27: 475-84. PMID 16060138 DOI: 10.1081/Jdi-65423 |
0.555 |
|
| 2005 |
Behets GJ, Verberckmoes SC, Oste L, Bervoets AR, Salomé M, Cox AG, Denton J, De Broe ME, D'Haese PC. Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate. Kidney International. 67: 1830-6. PMID 15840030 DOI: 10.1111/J.1523-1755.2005.00281.X |
0.559 |
|
| 2005 |
Oste L, Bervoets AR, Behets GJ, Dams G, Marijnissen RL, Geryl H, Lamberts LV, Verberckmoes SC, Van Hoof VO, De Broe ME, D'Haese PC. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats. Kidney International. 67: 920-30. PMID 15698431 DOI: 10.1111/J.1523-1755.2005.00156.X |
0.539 |
|
| 2004 |
Behets GJ, Dams G, Vercauteren SR, Damment SJ, Bouillon R, De Broe ME, D'Haese PC. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? Journal of the American Society of Nephrology : Jasn. 15: 2219-28. PMID 15284308 DOI: 10.1097/01.ASN.0000133022.32912.95 |
0.481 |
|
| 2004 |
Behets GJ, Verberckmoes SC, D'Haese PC, De Broe ME. Lanthanum carbonate: a new phosphate binder. Current Opinion in Nephrology and Hypertension. 13: 403-9. PMID 15199290 DOI: 10.1097/01.Mnh.0000133973.86816.E9 |
0.33 |
|
| 2004 |
De Broe ME, D'Haese PC. Improving outcomes in hyperphosphataemia. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 19: i14-8. PMID 15126649 DOI: 10.1093/Ndt/Gfh1003 |
0.585 |
|
| 2003 |
Verberckmoes SC, De Broe ME, D'Haese PC. Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney International. 64: 534-43. PMID 12846748 DOI: 10.1046/J.1523-1755.2003.00123.X |
0.529 |
|
| 2003 |
D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney International. Supplement. S73-8. PMID 12753271 DOI: 10.1046/J.1523-1755.63.S85.18.X |
0.432 |
|
| 2003 |
Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, Couttenye MM, De Broe ME, D'Haese PC. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 18: 1159-66. PMID 12748350 DOI: 10.1093/Ndt/Gfg116 |
0.563 |
|
| 2003 |
Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 41: 997-1007. PMID 12722034 DOI: 10.1016/S0272-6386(03)00197-5 |
0.466 |
|
| 2003 |
Schrooten I, Behets GJ, Cabrera WE, Vercauteren SR, Lamberts LV, Verberckmoes SC, Bervoets AJ, Dams G, Goodman WG, De Broe ME, D'Haese PC. Dose-dependent effects of strontium on bone of chronic renal failure rats. Kidney International. 63: 927-35. PMID 12631073 DOI: 10.1046/J.1523-1755.2003.00809.X |
0.824 |
|
| 2003 |
De Broe ME, D'Haese PC. Strontium and osteomalacia in renal failure patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 18: 215-6; author reply . PMID 12480989 DOI: 10.1093/Ndt/18.1.215 |
0.463 |
|
| 2003 |
D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients Kidney International, Supplement. 63. |
0.451 |
|
| 2000 |
Smans KA, D'Haese PC, Van Landeghem GF, Andries LJ, Lamberts LV, Hendy GN, De Broe ME. Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 15: 1328-36. PMID 10978387 DOI: 10.1093/Ndt/15.9.1328 |
0.408 |
|
| 2000 |
D'Haese PC, Schrooten I, Goodman WG, Cabrera WE, Lamberts LV, Elseviers MM, Couttenye MM, De Broe ME. Increased bone strontium levels in hemodialysis patients with osteomalacia. Kidney International. 57: 1107-14. PMID 10720963 DOI: 10.1046/J.1523-1755.2000.00938.X |
0.826 |
|
| 1999 |
Couttenye MM, D'Haese PC, Verschoren WJ, Behets GJ, Schrooten I, De Broe ME. Low bone turnover in patients with renal failure. Kidney International. Supplement. 73: S70-6. PMID 10633468 DOI: 10.1046/J.1523-1755.1999.07308.X |
0.831 |
|
| 1999 |
Schrooten I, Elseviers MM, Lamberts LV, De Broe ME, D'Haese PC. Increased serum strontium levels in dialysis patients: an epidemiological survey. Kidney International. 56: 1886-92. PMID 10571798 DOI: 10.1046/J.1523-1755.1999.00740.X |
0.819 |
|
| 1999 |
D'Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clinical Chemistry. 45: 1548-56. PMID 10471660 DOI: 10.1093/Clinchem/45.9.1548 |
0.821 |
|
| 1999 |
Wedeen RP, Udasin I, Fiedler N, D'Haese P, De Broe M, Gelpi E, Jones KW, Gochfeld M. Urinary biomarkers as indicators of renal disease Renal Failure. 21: 241-249. PMID 10416201 DOI: 10.3109/08860229909085086 |
0.468 |
|
| 1999 |
Cabrera WE, Schrooten I, De Broe ME, D'Haese PC. Strontium and bone. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 14: 661-8. PMID 10320513 DOI: 10.1359/Jbmr.1999.14.5.661 |
0.796 |
|
| 1999 |
D'Haese PC, De Broe ME. Trace metals in chronic renal failure patients treated by dialysis Trace Elements and Electrocytes. 16: 163-174. |
0.324 |
|
| 1998 |
Couttenye MM, D'Haese PC, De Broe ME. What considerations should we give to adynamic bone disease? International Journal of Artificial Organs. 21: 687-692. PMID 9894742 DOI: 10.1177/039139889802101102 |
0.506 |
|
| 1998 |
Ehrlich R, Robins T, Jordaan E, Miller S, Mbuli S, Selby P, Wynchank S, Cantrell A, De Broe M, D'Haese P, Todd A, Landrigan P. Lead absorption and renal dysfunction in a South African battery factory Occupational and Environmental Medicine. 55: 453-460. PMID 9816378 DOI: 10.1136/Oem.55.7.453 |
0.353 |
|
| 1998 |
Schrooten I, Cabrera W, Goodman WG, Dauwe S, Lamberts LV, Marynissen R, Dorriné W, De Broe ME, D'Haese PC. Strontium causes osteomalacia in chronic renal failure rats. Kidney International. 54: 448-56. PMID 9690211 DOI: 10.1046/j.1523-1755.1998.00035.x |
0.829 |
|
| 1997 |
Couttenye MM, D'Haese PC, Deng JT, Van Hoof VO, Verpooten GA, De Broe ME. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 12: 2144-50. PMID 9351080 DOI: 10.1093/ndt/12.10.2144 |
0.4 |
|
| 1997 |
D'Haese PC, Van Landeghem GF, Lamberts LV, Bekaert VA, Schrooten I, De Broe ME. Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometry. Clinical Chemistry. 43: 121-8. PMID 8990233 DOI: 10.1093/Clinchem/43.1.121 |
0.804 |
|
| 1996 |
D'Haese PC, Couttenye MM, De Broe ME. Diagnosis and treatment of aluminium bone disease Nephrology Dialysis Transplantation. 11: 74-79. PMID 8840316 |
0.471 |
|
| 1996 |
Smans KA, Van Landeghem GF, D'Haese PC, Couttenye MM, De Broe ME. Is there a link between erythropoietin therapy and adynamic bone disease? Nephrology Dialysis Transplantation. 11: 1248-1249. PMID 8672017 |
0.36 |
|
| 1996 |
Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients Nephrology Dialysis Transplantation. 11: 1065-1072. PMID 8671970 |
0.473 |
|
| 1994 |
D'Haese PC, Lamberts LV, Verpooten GA, Vaneerdeweg W, Jurgens A, Arakelian S, Babloyan A, Digenis P, Tjalma W, De Broe ME. Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function Kidney International. 45: 76-84. PMID 8127024 DOI: 10.1038/Ki.1994.9 |
0.438 |
|
| 1993 |
van Ginkel MF, van der Voet GB, D'Haese PC, De Broe ME, de Wolff FA. Effect of citric acid and maltol on the accumulation of aluminum in rat brain and bone. The Journal of Laboratory and Clinical Medicine. 121: 453-60. PMID 8445293 |
0.346 |
|
| 1991 |
Liang L, D'Haese PC, Lamberts LV, De Broe ME. Direct calibration for determining aluminum in bone and soft tissues by graphite furnace atomic absorption spectrometry Clinical Chemistry. 37: 461-466. PMID 2004458 DOI: 10.1093/Clinchem/37.3.461 |
0.424 |
|
| 1991 |
Jorens PG, Van De Vyver FL, Nuyts GD, Daelemans RA, D'Haese PC, Elseviers MM, De Broe ME, Winterberg B, Korte R, Bertram HP. Bone lead and renal failure [7] Nephron. 58: 494-497. PMID 1922624 DOI: 10.1159/000186492 |
0.523 |
|
| 1991 |
Van De Vyver FL, D'Haese PC, De Broe ME. Detection of aluminium and iron in bone in patients with chronic renal failure. A survey Nieren- Und Hochdruckkrankheiten. 20: 321-327. |
0.471 |
|
| 1991 |
De Broe ME, D'Haese PC, Van De Vyver FL, Lamberts LV. Aluminum-related bone disease in dialysis patients: Pathophysiology, diagnosis and therapy Nieren- Und Hochdruckkrankheiten. 20: 311-316. |
0.384 |
|
| 1990 |
D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, Visser WJ, De Broe ME. Value of serum aluminium monitoring in dialysis patients: a multicentre study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 5: 45-53. PMID 2109284 DOI: 10.1093/Ndt/5.1.45 |
0.392 |
|
| 1989 |
Van De Vyver FL, Visser WJ, D'haese PC, Silva FJE, Thomas H, De Broe ME. Risk of aluminium intoxication in long-term acetate redy dialysis Nephrology Dialysis Transplantation. 4: 555-562. PMID 2507978 DOI: 10.1093/Oxfordjournals.Ndt.A091912 |
0.549 |
|
| 1988 |
Van de Vyver FL, Visser WJ, D'Haese PC, De Broe ME. Iron overload and bone disease in chronic dialysis patients Contributions to Nephrology. 64: 134-143. PMID 3180820 DOI: 10.1093/Ndt/5.9.781 |
0.542 |
|
| 1988 |
Wedeen RP, Van de Vyver FL, D'Haese PC, Visser WJ, Elseviers MM, Knippenberg LJ, Lamberts LV, De Broe ME, Batuman V, Schidlovsky G. Bone lead and the diagnosis of lead nephropathy Contributions to Nephrology. 64: 102-108. PMID 3141113 DOI: 10.1159/000415732 |
0.402 |
|
| 1988 |
Van De Vyver FL, D'Haese PC, Visser WJ, Elseviers MM, Knippenberg LJ, Lamberts LV, Wedeen RP, De Broe ME. Bone lead in dialysis patients Kidney International. 33: 601-607. PMID 3129611 DOI: 10.1038/Ki.1988.39 |
0.593 |
|
| 1988 |
Diaz Lopez JB, D'Haese PC, Nouewen EJ, Lamberts LV, Cannata JB, De Broe ME. Aluminium uptake by the parathyroid glands in aluminium-loaded rats with renal failure Nefrologia. 8: 35-41. |
0.312 |
|
| 1987 |
Roodhooft AM, van de Vyver FL, D'Haese PC, van Acker KJ, Visser WJ, de Broe ME. Aluminum accumulation in children on chronic dialysis: Predictive value of serum aluminum levels and desferrioxamine infusion test Clinical Nephrology. 28: 125-129. PMID 3665205 |
0.317 |
|
| 1986 |
Ritz E, Roster J, De Broe ME, Van De Vyver FL, D'haese PC, Stoeppler M, Wedee RP. Does lead exposure contribute to deterioration of renal function in patients with renal disease Nephrology Dialysis Transplantation. 1: 206-207. PMID 3110675 DOI: 10.1093/Oxfordjournals.Ndt.A091477 |
0.444 |
|
| 1986 |
Van de Vyver FL, Bekaert AB, D'Haese PC. Serum, blood, bone and liver aluminum levels in chronic renal failure Trace Elements in Medicine. 3: 52-61. |
0.392 |
|
| Show low-probability matches. |